Reducing Distress and Depressive-symptoms in Rural Women

Sponsor
University of Nebraska (Other)
Overall Status
Completed
CT.gov ID
NCT03465813
Collaborator
University of Kansas Medical Center (Other)
33
1
2
22.3
1.5

Study Details

Study Description

Brief Summary

Of the 3.1 million U.S. breast cancer survivors, approximately 30% experience significant cancer-related distress ranging from sub-threshold to diagnosable adjustment disorders, depression-symptoms and major depression up to 20 years after diagnosis. Rural cancer survivors report poorer mental health than urban survivors. Lack of access to care, support and stigma associated with cancer and mental health, challenge rural women's ability to prevent cancer-related distress and its deleterious outcomes. These barriers may be overcome by a new Internet-based, psychoeducational program designed for newly diagnosed women; CaringGuidance™- After Breast Cancer Diagnosis. This self-guided program provides information, cognitive-behavioral and supportive coping strategies in a text/audio/visual format accessed via Internet/mobile devices to increase understanding, and provide supportive tools to prevent/manage distress and depressive-symptoms.

The aims of this pilot study are to determine preliminary efficacy of the CaringGuidance™ program on distress and depressive-symptoms monthly and over 3 months, for rural women newly diagnosed with breast cancer, and trial measures and methods, prior to a fully powered RCT.

Sixty rural women, will be randomized to 3 months of self-guided CaringGuidance™ program access with usual care or usual care alone. Both groups complete monthly standard psychosocial measures, daily activity/symptom logs and receive a monthly call. Program engagement/dose will be measured by the CaringGuidance™ internal data system. Descriptive and inferential statistics will characterize the sample and determine differences between groups at monthly intervals and overall. Variability of outcome variables will also be assessed to determine usefulness.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CaringGuidance After Breast Cancer Diagnosis
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
33 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Reducing Distress and Depressive-symptoms in Rural Women Using CaringGuidance™-After Breast Cancer Diagnosis: Randomized Controlled Pilot Study
Actual Study Start Date :
Jul 19, 2017
Actual Primary Completion Date :
May 11, 2019
Actual Study Completion Date :
May 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: CaringGuidance Intervention

Three months of web-based CaringGuidance psychoeducational program use, independently on home computer in addition to usual care.

Behavioral: CaringGuidance After Breast Cancer Diagnosis
CaringGuidance After Breast Cancer Diagnosis, psychoeducational, Internet-accessible program

No Intervention: Usual Care

Three months of care as usual from subjects' clinics and community as the subject chooses.

Outcome Measures

Primary Outcome Measures

  1. change from baseline in distress at 1, 2, and 3 months [at baseline and months 1, 2, and 3]

    self-report of psychological distress

  2. change from baseline in depressive-symptoms at 1, 2, and 3 months [at baseline and months 1, 2, and 3]

    self-report of depressive-symptoms

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 85 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • experiencing their first, stage 0 - IIIA breast cancer diagnosis (either clinical or definitive early stage at enrollment), and be 19 to 85 years of age,

  • enroll < 3 months post-diagnosis (as soon as possible after diagnosis is desirable),

  • reside in a non-metro county of the United States according to the USDA Rural-Urban Continuum Codes (6 -9) (RUCC) or at a rural zip-code by the USDA Rural Urban Commuting Area (RUCA) codes (4.0, 4.2, 5.0, 5.2, 6.0, 6.1, 7.0, 7.2-4, 8.0, 8.2-4, 9.0-2, 10.0, 10.2-6)

  • be able to read and write in English since the CaringGuidance™ program is in English,

  • have regular access (e.g. home or work) to high speed/satellite broadband Internet on desk/laptop or wireless iPad, Android or iPhone throughout the 3 months of the study,*

  • have an email address at which to receive CaringGuidance™ prompts,

  • have a Baseline Distress Thermometer score of > 4, or an Impact of Events Scale score of > 9, or Center for Epidemiological Studies Depression Scale score of > 16 (i.e. clinically meaningful thresholds).

  • Able to comprehend and provide informed consent

Exclusion Criteria:
  • Men and women with recurrent or advanced breast cancer

  • Those mentally or physically unable to read the consent form or other study materials and/or participate in the consent and engagement with the CaringGuidance program. Women who have been hospitalized for mental health issues or substance abuse in the past year are ineligible.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Nebraska Medical Center Oncology Clinics Omaha Nebraska United States 68131

Sponsors and Collaborators

  • University of Nebraska
  • University of Kansas Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Robin Lally, PhD, RN, Professor, University of Nebraska
ClinicalTrials.gov Identifier:
NCT03465813
Other Study ID Numbers:
  • 140-17
First Posted:
Mar 14, 2018
Last Update Posted:
Jun 6, 2019
Last Verified:
Jun 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 6, 2019